Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)-RFA-IP-24-046, Nationwide Cohort To Estimate Burden of Respiratory Viruses and Immunologic Response (Blood Donor Cohort); Amended Notice of Closed Meeting, 14846 [2024-04199]

Download as PDF 14846 Federal Register / Vol. 89, No. 41 / Thursday, February 29, 2024 / Notices in advance of the meeting, to Rashaun Roberts, Ph.D., Designated Federal Officer, National Center for Occupational Safety and Health, Centers for Disease and Prevention, 1090 Tusculum Avenue, Mailstop C–24, Cincinnati, Ohio 45226, Telephone: (513) 533–6800; Email: ocas@cdc.gov. Written comments received in advance of the meeting will be included in the official record of the meeting. The Director, Office of Strategic Business Initiatives, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Kalwant Smagh, Director, Office of Strategic Business Initiatives, Office of the Chief Operating Officer, Centers for Disease Control and Prevention. Kalwant Smagh, Director, Office of Strategic Business Initiatives, Office of the Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2024–04210 Filed 2–28–24; 8:45 am] BILLING CODE 4163–18–P [FR Doc. 2024–04199 Filed 2–28–24; 8:45 am] DEPARTMENT OF HEALTH AND HUMAN SERVICES khammond on DSKJM1Z7X2PROD with NOTICES and Immunologic Response (Blood Donor Cohort). Date: April 11, 2024. Time: 10 a.m.–5 p.m., EDT. The meeting is closed to the public. For Further Information Contact: Gregory Anderson, M.S., M.P.H., Scientific Review Officer, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, 1600 Clifton Road NE, Mailstop H24–6, Atlanta, Georgia 30329–4027. Telephone: (404) 718–8833; Email: GAnderson@cdc.gov. The Director, Office of Strategic Business Initiatives, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. BILLING CODE 4163–18–P Centers for Disease Control and Prevention DEPARTMENT OF HEALTH AND HUMAN SERVICES Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)—RFA–IP–24– 046, Nationwide Cohort To Estimate Burden of Respiratory Viruses and Immunologic Response (Blood Donor Cohort); Amended Notice of Closed Meeting Centers for Medicare & Medicaid Services Notice is hereby given of a change in the closed meeting of the Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)— RFA–IP–24–046, Nationwide Cohort to Estimate Burden of Respiratory Viruses and Immunologic Response (Blood Donor Cohort); April 11–12, 2024, 10 a.m.–5 p.m., EDT, videoconference, in the original Federal Register notice. The meeting notice was published in the Federal Register on January 16, 2024, Volume 89, Number 10, pages 2618– 2619. The notice is being amended to change the meeting dates to a one-day meeting and should read as follows: Name of Committee: Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)— RFA–IP–24–046, Nationwide Cohort to Estimate Burden of Respiratory Viruses VerDate Sep<11>2014 16:39 Feb 28, 2024 Jkt 262001 [Document Identifiers: CMS–10706 and CMS–10526] Agency Information Collection Activities: Proposed Collection; Comment Request Centers for Medicare & Medicaid Services, Health and Human Services (HHS). ACTION: Notice. AGENCY: The Centers for Medicare & Medicaid Services (CMS) is announcing an opportunity for the public to comment on CMS’ intention to collect information from the public. Under the Paperwork Reduction Act of 1995 (PRA), federal agencies are required to publish notice in the Federal Register concerning each proposed collection of information (including each proposed extension or reinstatement of an existing collection of information) and to allow 60 days for public comment on the proposed action. Interested persons are invited to send comments regarding our burden estimates or any other aspect of this collection of information, including SUMMARY: PO 00000 Frm 00047 Fmt 4703 Sfmt 4703 the necessity and utility of the proposed information collection for the proper performance of the agency’s functions, the accuracy of the estimated burden, ways to enhance the quality, utility, and clarity of the information to be collected, and the use of automated collection techniques or other forms of information technology to minimize the information collection burden. DATES: Comments must be received by April 29, 2024. ADDRESSES: When commenting, please reference the document identifier or OMB control number. To be assured consideration, comments and recommendations must be submitted in any one of the following ways: 1. Electronically. You may send your comments electronically to https:// www.regulations.gov. Follow the instructions for ‘‘Comment or Submission’’ or ‘‘More Search Options’’ to find the information collection document(s) that are accepting comments. 2. By regular mail. You may mail written comments to the following address: CMS, Office of Strategic Operations and Regulatory Affairs, Division of Regulations Development, Attention: Document Identifier/OMB Control Number: ll, Room C4–26–05, 7500 Security Boulevard, Baltimore, Maryland 21244–1850. To obtain copies of a supporting statement and any related forms for the proposed collection(s) summarized in this notice, please access the CMS PRA website by copying and pasting the following web address into your web browser: https://www.cms.gov/ Regulations-and-Guidance/Legislation/ PaperworkReductionActof1995/PRAListing. FOR FURTHER INFORMATION CONTACT: William N. Parham at (410) 786–4669. SUPPLEMENTARY INFORMATION: Contents This notice sets out a summary of the use and burden associated with the following information collections. More detailed information can be found in each collection’s supporting statement and associated materials (see ADDRESSES). CMS–10706 Generic Clearance for the Center for Clinical Standards and Quality IT Product and Support Teams CMS–10526 Cost-sharing Reduction Reconciliation Under the PRA (44 U.S.C. 3501– 3520), federal agencies must obtain approval from the Office of Management and Budget (OMB) for each collection of E:\FR\FM\29FEN1.SGM 29FEN1

Agencies

[Federal Register Volume 89, Number 41 (Thursday, February 29, 2024)]
[Notices]
[Page 14846]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-04199]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP)--RFA-IP-24-046, Nationwide Cohort To Estimate 
Burden of Respiratory Viruses and Immunologic Response (Blood Donor 
Cohort); Amended Notice of Closed Meeting

    Notice is hereby given of a change in the closed meeting of the 
Disease, Disability, and Injury Prevention and Control Special Emphasis 
Panel (SEP)--RFA-IP-24-046, Nationwide Cohort to Estimate Burden of 
Respiratory Viruses and Immunologic Response (Blood Donor Cohort); 
April 11-12, 2024, 10 a.m.-5 p.m., EDT, videoconference, in the 
original Federal Register notice. The meeting notice was published in 
the Federal Register on January 16, 2024, Volume 89, Number 10, pages 
2618-2619.
    The notice is being amended to change the meeting dates to a one-
day meeting and should read as follows:
    Name of Committee: Disease, Disability, and Injury Prevention and 
Control Special Emphasis Panel (SEP)--RFA-IP-24-046, Nationwide Cohort 
to Estimate Burden of Respiratory Viruses and Immunologic Response 
(Blood Donor Cohort).
    Date: April 11, 2024.
    Time: 10 a.m.-5 p.m., EDT.
    The meeting is closed to the public.

    For Further Information Contact: Gregory Anderson, M.S., M.P.H., 
Scientific Review Officer, National Center for HIV, Viral Hepatitis, 
STD, and TB Prevention, Centers for Disease Control and Prevention, 
1600 Clifton Road NE, Mailstop H24-6, Atlanta, Georgia 30329-4027. 
Telephone: (404) 718-8833; Email: [email protected].
    The Director, Office of Strategic Business Initiatives, Office of 
the Chief Operating Officer, Centers for Disease Control and 
Prevention, has been delegated the authority to sign Federal Register 
notices pertaining to announcements of meetings and other committee 
management activities, for both the Centers for Disease Control and 
Prevention and the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Office of Strategic Business Initiatives, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2024-04199 Filed 2-28-24; 8:45 am]
BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.